This complete guide covers ~130 approved peptide drugs plus 2024-2025 new approvals ~130 peptide drugs now FDA approved: Four new TIDES (peptides and oligonucleotides) received FDA approval in 2024 alone 2024-2025 new approvals: Yorvipath (hypoparathyroidism), Aqneursa (Niemann-Pick), Lumisight (breast cancer imaging), Forzinity (Barth syndrome) GLP-1 compounding restrictions: Tirzepatide and semaglutide compounding ended in early 2025 following shortage resolution 2026 pipeline: Retatrutide, CagriSema, and survodutide are in late-stage trials with potential approvals Research peptides remain distinct: Compounds like BPC-157, TB-500 , and Ipamorelin are NOT FDA approved Introduction: The Peptide Therapeutics Revolution If you're searching for a list of FDA approved peptide drugs , a comprehensive FDA approved injectable peptides list , or wondering which peptides are FDA approved for human use this is the current list of clinically approved peptide therapeutics covering every approved compound with indications and manufacturer details

Our premium liposomal formula provides essential structural support for natural liver function and hepatic metabolic pathways, helping to maintain your bodys natural defense systems while supporting daily energy metabolism and focus
Importantly, BPC-157 also induces expression of EGR-1 and its corepressor NAB2, forming a regulatory feedback loop that modulates the duration and amplitude of angiogenic gene transcription during wound healing
Alpha-MSH modulates cell adhesion and inflammatory responses of synovial fibroblasts from osteoarthritis patients